These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 11505783

  • 1. Endothelin receptor antagonist activity of (R)-(-)-2-(benzo[1,3]dioxol-5-yl)-N-(4-isopropylphenylsulfonyl)-2-(6-methyl- 2-propylpyridin-3-yloxy)acetamide hydrochloride (PABSA) in rat aortic smooth muscle cells and isolated rat thoracic aorta.
    Iwasaki T, Hayasaki-Kajiwara Y, Matsuo Y, Nakajima M.
    Arzneimittelforschung; 2001; 51(7):529-34. PubMed ID: 11505783
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist.
    Iwasaki T, Mihara S, Shimamura T, Kawakami M, Hayasaki-Kajiwara Y, Naya N, Fujimoto M, Nakajima M.
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):139-47. PubMed ID: 10413080
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
    Ohlstein EH, Nambi P, Hay DW, Gellai M, Brooks DP, Luengo J, Xiang JN, Elliott JD.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
    [Abstract] [Full Text] [Related]

  • 5. Nonpeptidic antagonists of ETA and ETB receptors reverse the ET-1-induced sustained increase of cytosolic and nuclear calcium in human aortic vascular smooth muscle cells.
    Bkaily G, Choufani S, Avedanian L, Ahmarani L, Nader M, Jacques D, D'Orléans-Juste P, Al Khoury J.
    Can J Physiol Pharmacol; 2008 Aug; 86(8):546-56. PubMed ID: 18758503
    [Abstract] [Full Text] [Related]

  • 6. The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature.
    Xu J, Li N, Dai DZ, Yu F, Dai Y.
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):42-8. PubMed ID: 18594475
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
    Ohlstein EH, Nambi P, Lago A, Hay DW, Beck G, Fong KL, Eddy EP, Smith P, Ellens H, Elliott JD.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
    [Abstract] [Full Text] [Related]

  • 10. Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.
    Masuda Y, Sugo T, Kikuchi T, Kawata A, Satoh M, Fujisawa Y, Itoh Y, Wakimasu M, Ohtaki T.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):675-85. PubMed ID: 8930171
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery.
    Devadason PS, Henry PJ.
    Br J Pharmacol; 1997 May; 121(2):253-63. PubMed ID: 9154335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vasoactivity mediated by endothelin ETA and ETB receptors in isolated porcine ophthalmic artery.
    White LR, Bakken IJ, Sjaavaag I, Elsås T, Vincent MB, Edvinsson L.
    Acta Physiol Scand; 1996 Jun; 157(2):245-52. PubMed ID: 8800365
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endothelin ETB receptor antagonist, RES-701-1: effects on isolated blood vessels and small intestine.
    Karaki H, Sudjarwo SA, Hori M, Tanaka T, Matsuda Y.
    Eur J Pharmacol; 1994 Sep 12; 262(3):255-9. PubMed ID: 7813590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.